


Harold D.
Efficient and easy
In stock · arrives 2 to 4 working days after payment
Pay by card or PayPal (confirmed instantly), Instant EFT, EFT or crypto
Damaged or wrong? We replace or refund
Packed and shipped from Cape Town, South Africa. Dispatched within 24 to 36 hours, then tracked courier (Aramex or The Courier Guy) to your door in 1 to 3 working days.
Cagrilintide is a long-acting amylin analogue that acts on amylin receptors to reduce appetite and slow gastric emptying via a different pathway than GLP-1 agonists.
Where we hold an independent Janoshik report for a compound we publish it in full - batch number, purity and a verification key you can check against the lab yourself. Where we do not hold one the product is marked research grade and we say so, rather than claim a report we cannot produce.
The short version: Cagrilintide is Novo Nordisk's long-acting copy of amylin, a fullness hormone made in the pancreas. It is best known as the partner in CagriSema, but it has its own trial record and now its own phase 3 programme.
Amylin is a hormone made in the pancreas that tells the brain you have had enough to eat. Cagrilintide is a long-acting version, given once a week in trials. Researchers describe it as a non-selective amylin receptor agonist, meaning it does not single out one receptor in the amylin family. That detail matters, because newer rivals such as eloralintide were designed to be more choosy.
The first big test was a phase 2 trial in The Lancet (2021): 706 adults on cagrilintide across 57 sites in ten countries, South Africa among them, compared with placebo and with daily liraglutide, an older GLP-1 drug. After 26 weeks, weight was down 10.8% at the highest dose tested, against 3.0% on placebo and 9.0% on liraglutide. Nausea, constipation, diarrhoea and injection-site reactions were the common complaints.
Cagrilintide also ran as its own arm inside the REDEFINE 1 phase 3 trial of CagriSema. Over 68 weeks that arm averaged 11.8% weight loss against 2.3% on placebo, first shown at the EASD meeting in 2025. Off the back of that, Novo started the RENEW phase 3 programme for cagrilintide alone in November 2025.
On its own, cagrilintide sits at roughly half the weight loss of the combination, and RENEW has not reported yet. It is not approved anywhere as a single drug. All of the data come from Novo's pharmaceutical material in supervised trials, which tells you nothing about a research vial.
It arrives as a freeze-dried powder. Once bacteriostatic water goes in, it belongs in the fridge. Our reconstitution and storage guide covers the details, and the calculator does the maths.
A week-long amylin mimic with real human data, but on its own it trails the GLP-1 drugs by a clear margin.
For research use only. Not for human consumption. Nothing on this page is medical advice.
No reviews from orders with Cagrilintide yet. Here is what recent customers said about ordering from us.
★★★★★
Efficient and easy
Harold D. · 18 Nov 2026
★★★★★
I went on holiday and stressed that I would not get my research materials in time, but you and the delivery company did not disappoint! Thank you for excellent pre order advice on products, user friendly ordering system, and superb delivery system!!!
Nicoleen · 18 Nov 2026
★★★★★
You guys are the best. Prices are good and service is outstanding
Glenda S. · 17 Nov 2026
★ 4.9 across all 117 AP reviews, good and bad. See them. Every reviewer gets R100 store credit, whatever they rate.
The same pairing in a single vial. Half the total peptide of the full stack below, and the cheaper way in.
The compound most often researched alongside metabolic compounds.
Filed in the same research area as the compound you are viewing.
The GHRH + GHRP pairing most commonly researched alongside a GLP-1.
A mitochondrial-derived peptide commonly researched alongside a GLP-1.
A GHRH analogue often researched in GLP-1 body-composition work.
A copper peptide researched for skin & tissue alongside a GLP-1.
A cellular-energy & longevity-research staple often researched alongside a GLP-1.
Follow my channel — every couple of weeks I drop one genuinely useful thing: how to read a COA, reconstitution math, the odd honest deal. No spam, no hype.
Follow Lab Notes on WhatsAppFree · follow & mute anytime · research use only. New here? WELCOME99 = R99 off a first order of R400 or more (doesn’t stack with sale discounts) →
Please read before entering this website.
All products offered on this website are strictly intended for scientific research and laboratory use only. They are not intended for human consumption, veterinary use, or any other purpose outside of controlled research environments.
These products have not been evaluated, approved, or certified by the South African Health Products Regulatory Authority (SAHPRA), the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), or any other regulatory authority for use in humans or animals.
By entering this website you confirm that:
AP accepts no liability for misuse of any product sold on this platform.
Join our email list and we’ll put WELCOME99 on your basket now: R99 off a first order of R400 or more. You’ll get restock news and the odd offer. Unsubscribe any time.
One use per email, first order only. Doesn’t stack with sale discounts. Research use only.
It’s on your basket: R99 off your first order of R400 or more.
Go to checkoutWe only deliver in South Africa for now. Tell us where you are, and we’ll let you know if we start delivering there.
We only use this to tell you about delivery to your country.
We’re counting where people want delivery. The countries with the most interest come first.
Chats are read by the AP team to help you. Never share card details here. Prefer a person? WhatsApp us